Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans

Sponsor
Julieta María Méndez Romero (Other)
Overall Status
Completed
CT.gov ID
NCT04485520
Collaborator
(none)
40
1
2
30
40.6

Study Details

Study Description

Brief Summary

Papaya has effects on oral pathogenic microorganisms, it also has anticoagulant quality, amebicidal action, antimicrobial, bacteriostatic and antifungal activity on different bacteria, especially on Streptococcus mutans, this can be exploited in the dental area. The objective of the study was to determine the efficacy of Carica Papaya peel extract (suckling) as an inhibitor of Streptococcus Mutans in students of the dental faculty of the National University of Caaguazú in 2018.

Condition or Disease Intervention/Treatment Phase
  • Other: CARICA PAPAYA MOUTHWASH
  • Other: CHLORHEXIDINE MOUTHWASH
N/A

Detailed Description

Specific objectives

  • To determine the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on Streptococcus Mutans by age and sex grouping.

  • To quantify the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on the growth of Streptococcus Mutans before, at 10 minutes and 8 days of use in the experimental group.

  • Quantify the inhibition of 0.12% Chlorhexidine Gluconate on the growth of Streptococcus Mutans before, after 10 minutes and 8 days of use in the control group.

  • Compare the count of Colony Forming Units (CFU) between both groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans in Students of the Faculty of Dentistry in the Year 2018
Actual Study Start Date :
Sep 21, 2017
Actual Primary Completion Date :
Oct 21, 2017
Actual Study Completion Date :
Oct 21, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Carica Papaya extract

Carica Papaya at 3%

Other: CARICA PAPAYA MOUTHWASH
Each application was 10 ml. applied for 1 minute, once a day for 8 days

Active Comparator: Chlorhexidine

0.12% chlorhexidine mouthwash formulation (commercially available)

Other: CHLORHEXIDINE MOUTHWASH
Each application was 10 ml. applied for 1 minute, once a day for 8 days

Outcome Measures

Primary Outcome Measures

  1. Number of Colony Forming units (Stage 1) [thorough study completion, an average of 24 hours]

    Before Intervention

  2. Number of Colony Forming units (Stage 2) [10 minutes after mouthwash use]

    After Intervention

  3. Number of Colony Forming units (Stage 3) [8 days after mouthwash use]

    After Intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants that signed the informed consent
Exclusion Criteria:
  • allergic to carica papaya

  • ongoing medical or dental treatment that could interfere with the results.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Facultad de Odontología Universidad Nacional de Caaguazú Coronel Oviedo International Paraguay 595

Sponsors and Collaborators

  • Julieta María Méndez Romero

Investigators

  • Principal Investigator: Diego Céspedes, Facultad de Odontología, Universidad Nacional de Caaguazu
  • Study Director: Ulises A Villasanti Torales, Facultad de Odontologia, Universidad Nacional de Caaguazu

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Julieta María Méndez Romero, Head of Writting and Publication Department, Regional Health Research Institute, Universidad Nacional de Caaguazu
ClinicalTrials.gov Identifier:
NCT04485520
Other Study ID Numbers:
  • 00140
First Posted:
Jul 24, 2020
Last Update Posted:
Aug 18, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Julieta María Méndez Romero, Head of Writting and Publication Department, Regional Health Research Institute, Universidad Nacional de Caaguazu
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2021